Votre panier est vide.
Psilocybin Science & News
Stay up to date with psilocybin research and psychedelic science. Here you’ll find easy-to-read explainers, study breakdowns, and news on therapy, safety, and new discoveries around magic mushrooms.
-
Published March 18, 2026 · 6 min read
A landmark JAMA study published on March 10, 2026 provides the first causal evidence that Oregon psilocybin decriminalization directly increased use. In Oregon — the first US state to decriminalize magic mushrooms — roughly 90,000 additional people used psilocybin each year after Measure 110. As a result, the findings carry major implications for drug policy worldwide.
Germany — Psilocybin Therapy | Updated March 2026
Germany has approved the first psilocybin therapy Compassionate Use programme in the EU — offering a supervised clinical pathway for people with treatment-resistant depression who have run out of options.
In this article, we explain what this psilocybin therapy programme involves, who it is for, and what the research shows so far.
Scientists have just described a new magic mushroom species — and it turns out millions of growers have been cultivating it for years without knowing. The new magic mushroom species is called Psilocybe ochraceocentrata, and it was hiding in plain sight behind the popular names "Natal Super Strength" (NSS) and "Transkei." In other words, these were never strains of Psilocybe cubensis at all. And here at Magic Mushrooms Shop, we already carry the world's first hybrid made from this new magic mushroom species: the Yellow Umbo.
Psilocybin legalisation is no longer a distant dream — it is happening right now. In the first months of 2026, three major developments in the United States have shifted the legal landscape for magic mushrooms faster than ever before. A pharmaceutical company is preparing to file the first-ever psilocybin drug application with the FDA. The DEA has dramatically increased how much psilocybin can be legally produced. And more than a dozen U.S. states are actively writing psilocybin into law. Together, these events signal a turning point — not just for the U.S., but for the world.
Can psilocybin treat OCD? A groundbreaking Yale University study says yes — and the results are remarkable. In this first-ever randomized, placebo-controlled trial, just one dose of psilocybin — the psychoactive compound in magic mushrooms — reduced obsessive-compulsive disorder symptoms within 48 hours. Even more striking, the benefits lasted for months. For the millions of people living with treatment-resistant OCD, this psilocybin OCD research opens an entirely new door.
Ketamine Assisted Therapy 101
Février 12, 2024
Ketamine started as a surgical anesthetic. Today, it is one of the most promising tools in mental health treatment. If you struggle with treatment-resistant depression, PTSD, or chronic anxiety, ketamine-assisted therapy may offer the rapid relief you have been looking for.
In this guide, you will learn what ketamine is, how therapy sessions work, and what you need to know before you begin.
A clear guide to synthetic psychedelics — LSD, MDMA, 2C-B, ketamine, research chemicals, and the critical difference between tested and untested substances. (2026 Update)
How MDMA, psilocybin, and other psychedelics are being studied as tools for healing trauma — including the Gabor Maté perspective. (2026 Update)
Why magic mushroom spores don't contain psilocybin ?
Mars 10, 2023
Spores are a type of reproductive cell produced by fungi that are essential to their life cycle. In the case of magic mushrooms, spores are used to create new mycelial networks and ultimately, new fruiting bodies. However, one interesting fact about magic mushroom spores is that they do not contain psilocybin, the active compound responsible for the mushrooms' psychoactive effects.
Continuer à lireMyths & Misconceptions About Psychedelics: The Truth Behind 8 Common Claims
Septembre 26, 2022
Debunking the Most Common Myths and Misconceptions About Psychedelics (2026 Update)
Psychedelics have been surrounded by fear, rumour, and misinformation for decades. Much of what most people "know" about them was shaped not by science, but by political campaigns from the 1970s — campaigns designed to discourage use rather than inform. Today, with research from universities like Johns Hopkins and Imperial College London producing serious data, we have the tools to look at these myths more honestly.
